NCT04452305
- Conditions
- Autoimmune Diseases, Autoimmune Disorder, Cancer, +8 more
- Locations
-
- Magee-Womens Hospital Pittsburgh, Pennsylvania, United States
Clinical trial condition
Neoplasms
Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.
7,940 public trials
1,514 recruiting studies
Neoplasms trial results
NCT05858424
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Centre Leon Berard Lyon, France
NCT02972801
- Conditions
- Autoimmune Diseases, Autoimmune Disorders, Cancer, +5 more
- Locations
-
- Magee-Womens Hospital Pittsburgh, Pennsylvania, United States
NCT05733091
- Conditions
- Neoplasms, Tumors
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06623656
- Conditions
- Bronchial Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Weill Cornell Medicine New York, United States
Recruiting
STATIC - Statin Termination in Cancer
NCT07543432
- Conditions
- Cancer, Neoplasms
- Locations
-
- Stockholms Sjukhem Pallitive Care Stockholm, Sweden
- ASIH Stockholm Södra Stockholm, Sweden
- Conditions
- Neoplasms
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of Colorado - Anschutz Medical Campus - PPDS Aurora, Colorado, United States
- Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
- Florida Cancer Specialists - Sarasota (North Catttlemen Rd) Sarasota, Florida, United States
NCT07542496
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- CAC BLIDA, Algiers, Algeria 16000 Algiers, Algeria
- CHU Béni Messous, Algiers, Algeria 16000 Algiers, Algeria
NCT07542925
- Conditions
- Intensive Care Units, Neoplasms, Pathologic Processes, +3 more
- Locations
-
- Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
NCT06326411
- Conditions
- Glioma, MAPK Pathway Gene Mutation, MEK Mutation, +19 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- UCLA Hematology/Oncology Westwood, Los Angeles, California, United States
- Sarah Cannon Research Institute at Health ONE Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States